Detecting Mosaicism of Monosomy X Using FISH in Prenatal Samples: Post High Risk NIPT

Abstract

Noninvasive prenatal testing (NIPT) is a highly specific and sensitive aneuploidy screening method with low false positive results. Sex chromosome aneuploidy (SCA) is not picked up in prenatal ultrasounds, as they may not have antenatally identifiable features, except for hydrops in monosomy X cases. Women with high risk NIPT results for SCAs are recommended to go for invasive prenatal diagnosis for confirmation by diagnostic tests like chromosome microarray, karyotyping, and/or fluorescence in situ hybridization (FISH). We present two cases that showed a high risk for monosomy X on NIPT. Chromosomal microarray was negative for SCA. Further, FISH was done to confirm the results and confirm the presence of low level mosaicism for monosomy X. FISH proves to be the test of choice to detect low level mosaicism in high risk NIPT cases with high positive predictive values.

Keywords

cell free fetal DNA - noninvasive prenatal testing - mosaicism - monosomy X

Publication History

Article published online:
03 June 2024

• References

• 1 Li X, Ju D, Shi Y. et al. Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with “false negative” result due to confined placental mosaicism: a case report. Medicine (Baltimore) 2020; 99 (29) e20848
• 2 Reilly K, Doyle S, Hamilton SJ, Kilby MD, Mone F. Pitfalls of prenatal diagnosis associated with mosaicism. Obstet Gynaecol 2023; 25 (01) 28-37
• 3 Cherry AM, Akkari YM, Barr KM. et al. Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2017; 19 (08) 845-850
• 4 Deng C, Cheung SW, Liu H. Noninvasive prenatal screening for fetal sex chromosome aneuploidies. Expert Rev Mol Diagn 2021; 21 (04) 405-415
• 5 Bussolaro S, Raymond YC, Acreman ML. et al. The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2023; 5 (03) 100844
• 6 Xie X, Tan W, Li F. et al. Diagnostic cytogenetic testing following positive noninvasive prenatal screening results of sex chromosome abnormalities: report of five cases and systematic review of evidence. Mol Genet Genomic Med 2020; 8 (07) e1297
• 7 Wiktor A, Van Dyke DL. FISH analysis helps identify low-level mosaicism in Ullrich-Turner syndrome patients. Genet Med 2004; 6 (03) 132-135
• 8 Liu X, Liu S, Wang H, Hu T. Potentials and challenges of chromosomal microarray analysis in prenatal diagnosis. Front Genet 2022; 13 (01) 938183
• 9 Novik V, Moulton EB, Sisson ME. et al. The accuracy of chromosomal microarray testing for identification of embryonic mosaicism in human blastocysts. Mol Cytogenet 2014; 7 (01) 18
• 10 Knoll JHM, Lichter P. In situ hybridization to metaphase chromosomes and interphase nucleiCurr Protoc Hum Genet . 2005. ;Chapter 4:1–31.
• 11 Lall M, Mahajan S, Saviour P. et al. FISH is not suitable as a standalone test for detecting fetal chromosomal abnormalities. J Foetal Med 2015; 02 (02) 53-59
• 12 Wolff DJ, Van Dyke DL, Powell CM. Working Group of the ACMG Laboratory Quality Assurance Committee. Laboratory guideline for Turner syndrome. Genet Med 2010; 12 (01) 52-55
• 13 Tulay P, Ergoren MC, Alkaya A, Yayci E, Sag SO, Temel SG. Inconsistency of Karyotyping and Array Comparative Genomic Hybridization (aCGH) in a Mosaic Turner Syndrome Case. Glob Med Genet 2020; 7 (04) 128-132
• 14 Jing X, Liu H, Zhu Q. et al. Clinical selection of prenatal diagnostic techniques following positive noninvasive prenatal screening results in Southwest China. Front Genet 2022; 12 (January): 811414
• 15 Li S, Shi Y, Han X. et al. Prenatal diagnosis of chromosomal mosaicism in over 18,000 pregnancies: a five-year single-tertiary-center retrospective analysis. Front Genet 2022; 13: 876887